UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin
Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon
Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation
Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most advanced technologies into Vithas hospitals and clinics
Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient care
Philips delivers Q4 sales of EUR 6.0 billion, with 7% comp. sales growth; income from cont. operations increases to EUR 608 million, Adjusted EBITA margin improves 110 bps to 19.0%, and operating cash flow increases to EUR 1,305 million
Secureworks Connect to Unite 1,200 Security Professionals as Threat Actors Exploit Silos and Gaps in Industry Solutions and Software Supply Chain